Myriad Genetics Inc expected to post a loss of 10 cents a share - Earnings Preview

Myriad Genetics

04/05/2024 02:31

* Myriad Genetics Inc  MYGN.OQ   MYGN.O  is expected to show
a
rise in quarterly revenue when it reports  results on May 7 for
the period ending March 31 2024
    * The Salt Lake City Utah-based  company is expected to
report a
6.8% increase in revenue to $193.506 million from $181.2 million
a year ago, according to the mean estimate from 12 analysts,
based on LSEG data.The company's guidance on February 27 2024,
for the period ended March 31, was for revenue between $190.26
million and $195.70 million.
    * ​LSEG's mean analyst estimate for Myriad Genetics Inc is
for a
loss of 10 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 5
"hold" and 3 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Myriad
Genetics
Inc is $25.00​, above​ its last closing price of $19.47. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.01        0.01       0.04      Beat    214.2
 Sep. 30 2023  -0.08       -0.08      -0.03     Beat    63
 Jun. 30 2023  -0.09       -0.08      -0.08     Met     5.9​
 Mar. 31 2023  -0.19       -0.19      -0.21     Missed  -8.6
 ​​Dec.        -0.15       -0.16      -0.12     Beat    26.5
 31 2022                                                
 Sep. 30 2022  -0.04       -0.06      -0.19     Missed  -216.7
                                                        ​
 Jun. 30 2022  0.03        0.01       0.04      Beat    300
 Mar. 31 2022  -0.06       -0.07      -0.03     Beat    55.3
 This summary was machine generated May 4 at 01:31 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)